CRSF 7th Masterclass | Dr. Akhil Kapoor on Immunotherapy in Older Adults with Lung Cancer

Explore the evolving role of immunotherapy in treating lung cancer among older adults in this expert session from the Cancer Research and Statistic Foundation's (CRSF) 7th Masterclass in Lung Cancer, held on 19th July 2024. Join Dr. Akhil Kapoor, a leading oncologist, as he delves into the complexities and solutions for utilizing immunotherapy in elderly lung cancer patients.
Immunotherapy has revolutionized cancer treatment, but its application in older adults presents unique challenges. Dr. Kapoor addresses the specific issues related to aging, such as comorbidities, immune system decline, and the increased risk of side effects. This session sheds light on how healthcare professionals can navigate these challenges, offering tailored solutions that balance efficacy and safety.
Dr. Kapoor also discusses the latest research, clinical trial data, and real-world case studies that highlight the effectiveness of immunotherapy in older patients. He emphasizes the importance of patient selection, dosage adjustments, and continuous monitoring to ensure the best outcomes for this vulnerable population. By understanding the nuances of immunotherapy in the elderly, oncologists can better manage the treatment journey for older adults battling lung cancer.
This video is a must-watch for oncologists, healthcare professionals, researchers, and anyone involved in geriatric oncology and cancer care.
#CRSF #LungCancerMasterclass #Immunotherapy #GeriatricOncology #DrAkhilKapoor #CancerCare #LungCancer #ElderlyCancerCare #CancerTreatment #CRSFMasterclass2024